(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide - 2First foreign troop in new gang suppression force lands in Haiti to replace previous mission
- 3Scientists solve the mystery of 'impossible' merger of 'forbidden' black holes
- 4A 'rampaging lion' nebula roars to life in a stunning deep-space photo
- 5Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- Undeniably popular Historical centers: Where Craftsmanship and History Meet
- ‘This year nearly broke me as a scientist’ – US researchers reflect on how 2025’s science cuts have changed their lives
- Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- Understanding Various Sorts of Financial balances: An Extensive Outline
- German foreign minister backs abandoning EU's unanimity principle
- Israel has clear objectives south of Litani River, but will face difficult choices further north
- Find the Insider facts of Viable Advertising: Building a Positive Brand Picture
- What are parents to do as doctors clash with Trump administration over vaccines?
- Overlooked infertility care should be part of national health services, says WHO
